hui-kang liu

Dr. hui-kang liu

National Research Institute of Chinese Medicine, Taipei, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YHYung-Cheng Huang
Yung-Cheng Huang
HTHuey-Jen Tsay
Huey-Jen Tsay
MLMei-Kuang Lu
Mei-Kuang Lu
CLChien-Hung Lin
Chien-Hung Lin
CYChih-Wen Yeh
Chih-Wen Yeh
YSYoung-Ji Shiao
Young-Ji Shiao
Astragalus membranaceus is commonly used in traditional Chinese medicine for strengthening the host defense system. Astragalus membranaceus-polysaccharides is an effective component with various important bioactivities, such as immunomodulation, antioxidant, anti-diabetes, anti-inflammation and neuroprotection. In the present study, we determine the effects of Astragalus membranaceus-polysaccharides on metabolically stressed transgenic mice in order to develop this macromolecules for treatment of sporadic Alzheimer’s disease, a neurodegenerative disease with metabolic risk factors. Transgenic mice, at 10 weeks old prior to the appearance of senile plaques, were treated in combination of administrating high-fat diet and injecting low-dose streptozotocin to create the metabolically stressed mice model. Astragalus membranaceus-polysaccharides was administrated starting at 14 weeks for 7 weeks. We found that Astragalus membranaceus-polysaccharides reduced metabolic stress-induced increase of body weight, insulin and insulin and leptin level, insulin resistance, and hepatic triglyceride. Astragalus membranaceus-polysaccharides also ameliorated metabolic stress-exacerbated oral glucose intolerance, although the fasting blood glucose was only temporally reduced. In brain, metabolic stress-elicited astrogliosis and microglia activation in the vicinity of plaques was also diminished by Astragalus membranaceus-polysaccharides administration. The plaque deposition, however, was not significantly affected by Astragalus membranaceus-polysaccharides administration. These findings suggest that Astragalus membranaceus-polysaccharides may be used to ameliorate metabolic stress-induced diabesity and the subsequent neuroinflammation, which improved the behavior performance in metabolically stressed transgenic mice.

21 January 2010 in Phytomedicine
Verified
Journal Article
Closed access
YJY.-C. Juan
Y.-C. Juan
WTW.-J. Tsai
W.-J. Tsai
YLY.-L. Lin
Y.-L. Lin
GWG.-J. Wang
G.-J. Wang
JCJ.-J. Cheng
J.-J. Cheng
hui-kang liuhui-kang liu
hui-kang liu

1 October 2021 in Journal of Functional Foods
Verified
Journal Article
Open access
LLLin-Chien Lee
Lin-Chien Lee
YHYu-Chang Hou
Yu-Chang Hou
YHYing-Ying Hsieh
Ying-Ying Hsieh
YCYu-Hsin Chen
Yu-Hsin Chen
YSYuh-Chiang Shen
Yuh-Chiang Shen
hui-kang liuhui-kang liu
hui-kang liu

Verified
Journal Article
Open access
PDF file
YLYi Heng Lee
Yi Heng Lee
HHHao-Chieh Hsu
Hao-Chieh Hsu
PKPei-Chen Kao
Pei-Chen Kao
YSYoung-Ji Shiao
Young-Ji Shiao
SYSkye Hsin-Hsien Yeh
Skye Hsin-Hsien Yeh
HTHuey-Jen Tsay
Huey-Jen Tsay
Alzheimer’s disease (AD), a progressive neurodegenerative disease is highly associated with metabolic syndromes. We previously demonstrated that glycemic dysregulation and obesity are augmented in high fat diet (HFD)-treated APPswe/PS1dE9 (APP/PS1) transgenic mice. In the current study, the underlying mechanism mediating exacerbated metabolic stresses in HFD APP/PS1 transgenic mice was further examined. APP/PS1 mice developed insulin resistance and, consequently, impaired glucose homeostasis after 10 weeks on HFD. [18F]-2-fluoro-2-deoxy-d-glucose ([18F]-FDG) positron emission tomography showed that interscapular brown adipose tissue is vulnerable to HFD and AD-related pathology. Chronic HFD induced hyperphagia, with limited effects on basal metabolic rates in APP/PS1 transgenic mice. Excessive food intake may be caused by impairment of leptin signaling in the hypothalamus because leptin failed to suppress the food intake of HFD APP/PS1 transgenic mice. Leptin-induced pSTAT3 signaling in the arcuate nucleus was attenuated. Dysregulated energy homeostasis including hyperphagia and exacerbated obesity was elicited prior to the presence of the amyloid pathology in the hypothalamus of HFD APP/PS1 transgenic mice; nevertheless, cortical neuroinflammation and the level of serum Aβ and IL-6 were significantly elevated. Our study demonstrates the pivotal role of AD-related pathology in augmenting HFD-induced insulin and leptin resistance and impairing hypothalamic regulation of energy homeostasis.


6 September 2018 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YLYu-Heng Lai
Yu-Heng Lai
CSCheng-Pu Sun
Cheng-Pu Sun
HHHSIU-CHEN HUANH
HSIU-CHEN HUANH
JCJui-Chieh Chen
Jui-Chieh Chen
hui-kang liuhui-kang liu
hui-kang liu
CHCheng Huang
Cheng Huang
Persistent hepatitis B virus (HBV) infection causes liver cirrhosis and hepatocellular carcinoma and constitutes a major worldwide health problem. Currently, anti-HBV drugs are limited to peginterferon and nucleos(t)ide analogs, which are costly and have considerable side effects; the development of novel, effective anti-HBV agents is crucial. Catechins are a major group of compounds found in green tea extract and epigallocatechin gallate (EGCG) has been shown to have antiviral properties, including inhibition of cellular entry by HBV. FRG (Fah−/−/ Rag2−/−/ IL-2Rγ/−) mice were used in this study to generate chimeras carrying human primary hepatocytes, to facilitate investigation of the inhibitory effect of EGCG on HBV infection. Here, we show the inhibitory effect of EGCG on HBV infection and replication in HuS-E/2 cells. The inhibitory effect of EGCG on HBV infection in vivo was confirmed by monitoring HBV DNA and HBsAg in serum and immunostaining the liver tissues of the human liver chimeric mice. The effects of EGCG suggest a robust strategy for the treatment of HBV infection and EGCG may have therapeutic potential for the treatment of HBV-associated liver diseases.